The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association with consolidation chemotherapy after concurrent chemoradiotherapyfollowed by surgery and the disease free survival in patients with stage III non-small cell lung cancer (NSCLC).
 
Yuka Kato
No Relationships to Disclose
 
Katsuyuki Hotta
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Lilly; Nippon Kayaku; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Lilly
Research Funding - Chugai Pharma; Lilly; MSD
Travel, Accommodations, Expenses - AstraZeneca
 
Go Makimoto
No Relationships to Disclose
 
Takashi Ninomiya
No Relationships to Disclose
 
Toshio Kubo
No Relationships to Disclose
 
Kadoaki Ohashi
No Relationships to Disclose
 
Eiki Ichihara
No Relationships to Disclose
 
Akiko Sato
No Relationships to Disclose
 
Masahiro Tabata
No Relationships to Disclose
 
Susumu Kanazawa
No Relationships to Disclose
 
Shinichi Toyooka
Honoraria - Taiho Pharmaceutical
Research Funding - Nippon Kayaku; Taiho Pharmaceutical
 
Mitsune Tanimoto
No Relationships to Disclose
 
Katsuyuki Kiura
Honoraria - Astellas Pharma; Chugai Pharma; Pfizer
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)